Home › Funds › Tetragon Partners GP Ltd › ACRS
Tetragon Partners GP Ltd position in ACRS
ACLARIS THERAPEUTICS INC · Health Care
Tetragon Partners GP Ltd reported holding 400,000 shares of ACRS (ACLARIS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.1M, representing 0.34% of its reported portfolio and ranking #31 among its reported holdings. Tetragon Partners GP Ltd first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Tetragon Partners GP Ltd's ACRS position evolved
Tetragon Partners GP Ltd first disclosed a stake in ACRS in Q2 2026 at 400,000 shares (US$2.1M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 400.00K | $2.12M | New |
About ACRS and 13F data
ACRS (ACLARIS THERAPEUTICS INC) is a Health Care company. 43 other funds we track also report a position in ACRS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$67.3M), BML Capital Management, LLC (US$63.3M), Deep Track Capital, LP (US$49.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ACRS
- RA CAPITAL MANAGEMENT, L.P. 12.72M sh · $67.30M · Q2 2026
- BML Capital Management, LLC 11.97M sh · $63.35M · Q2 2026
- Deep Track Capital, LP 9.35M sh · $49.44M · Q2 2026
- Vivo Capital, LLC 6.69M sh · $35.41M · Q2 2026
- Frazier Life Sciences Management, L.P. 4.93M sh · $26.06M · Q2 2026
- Rock Springs Capital Management LP 4.33M sh · $22.91M · Q2 2026
- Decheng Capital LLC 4.04M sh · $21.38M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.95M sh · $10.30M · Q2 2026
- Kalehua Capital Management LLC 1.83M sh · $9.69M · Q2 2026
- Jones Hill Capital LP 1.76M sh · $9.31M · Q2 2026
- Palo Alto Investors LP 1.61M sh · $8.54M · Q2 2026
- MPM BioImpact LLC 1.04M sh · $5.51M · Q2 2026
More on Tetragon Partners GP Ltd
FAQ
How long has Tetragon Partners GP Ltd held ACRS?
Tetragon Partners GP Ltd has disclosed ACRS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Tetragon Partners GP Ltd's current position in ACRS?
As of Q2 2026, Tetragon Partners GP Ltd holds 400.00K shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $2.12M, representing 0.34% of its reported portfolio and ranking #31.
Has Tetragon Partners GP Ltd been buying or selling ACRS?
In the latest 13F filing (Q2 2026), Tetragon Partners GP Ltd newly opened its position in ACRS.
Which other funds hold ACRS?
Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Deep Track Capital, LP, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.